MCID: INT075
MIFTS: 55

Intracranial Hypertension malady

Category: Neuronal diseases

Aliases & Classifications for Intracranial Hypertension

About this section

Aliases & Descriptions for Intracranial Hypertension:

Name: Intracranial Hypertension 10 46 47 12 36 65
 
Raised Intracranial Pressure 10

Classifications:



External Ids:

Disease Ontology10 DOID:9428
MeSH36 D019586
NCIt42 C84791
UMLS65 C0151740

Summaries for Intracranial Hypertension

About this section
NINDS:46 Pseudotumor cerebri literally means "false brain tumor." It is likely due to high pressure within the skull caused by the buildup or poor absorption of cerebrospinal fluid (CSF). The disorder is most common in women between the ages of 20 and 50. Symptoms of pseudotumor cerebri, which include headache, nausea, vomiting, and pulsating sounds within the head, closely mimic symptoms of large brain tumors.

MalaCards based summary: Intracranial Hypertension, also known as raised intracranial pressure, is related to pulmonary edema and meningitis, and has symptoms including restlessness, weakness and actual discomfort. An important gene associated with Intracranial Hypertension is OGG1 (8-Oxoguanine DNA Glycosylase), and among its related pathways are LDL Oxidation in Atherogenesis and Bile secretion. The drugs thiopental and urea have been mentioned in the context of this disorder. Affiliated tissues include brain, liver and bone, and related mouse phenotypes are integument and mortality/aging.

Related Diseases for Intracranial Hypertension

About this section

Diseases related to Intracranial Hypertension via text searches within MalaCards or GeneCards Suite gene sharing:

(show top 50)    (show all 367)
idRelated DiseaseScoreTop Affiliating Genes
1pulmonary edema30.5CD40LG, CD79A
2meningitis30.2AQP4, IL1B, TNF
3lateral sinus thrombosis29.9F5, SERPINC1
4sjogren's syndrome29.8CD40LG, TNF
5meningoencephalocele29.2F5, IL1B, SERPINC1
6thrombophilia28.9F2, F5, MTHFR, SERPINC1
7osteopetrosis28.9F2, F5, MTHFR, SERPINC1
8pseudotumor cerebri12.1
9amelia cleft lip palate hydrocephalus iris coloboma10.7F5, MTHFR
10muller barth menger syndrome10.7F5, MTHFR
11typhus10.7CD40LG, CD79A
12congenital hypogammaglobulinemia10.7CD40LG, CD79A
13calabro syndrome10.7CD40LG, CD79A
14gamma heavy chain disease10.7CD40LG, CD79A
15azygos continuation of the inferior vena cava10.7F5, MTHFR
16exanthema subitum10.7CD40LG, CD79A
17osteomalacia10.7CD40LG, CD79A
18epidermolysis bullosa simplex10.7CD40LG, CD79A
19proliferative glomerulonephritis10.7CD40LG, CD79A
20cryopyrin-associated periodic syndrome10.7CD40LG, CD79A
21nephrolithiasis10.7AQP4, MTHFR
22tall stature-scoliosis-macrodactyly of the great toes syndrome10.7F2, F5
23acute salpingitis10.7CD40LG, CD79A
24beriberi10.7CD40LG, CD79A
25cavernous sinus thrombosis10.7F5, MTHFR
26cystitis10.7CD40LG, CD79A
27purpura10.7CD40LG, CD79A
28choroid plexus meningioma10.7CD40LG, CD79A
29immunotactoid glomerulopathy10.7CD40LG, CD79A
30breast abscess10.7F5, MTHFR
31subacute delirium10.6CD40LG, CD79A
32alpha chain disease10.6CD40LG, CD79A
33internuclear ophthalmoplegia10.6F2, F5
34dysgammaglobulinemia10.6CD40LG, CD79A
35generalized atherosclerosis10.6CD40LG, CD79A
36central sleep apnea10.6CD40LG, CD79A
37sialadenitis10.6CD40LG, CD79A
38ureteral lymphoma10.6CD40LG, CD79A
39mixed lacrimal gland cancer10.6CD40LG, CD79A
40pulmonary fibrosis, familial10.6F2, MTHFR
41aids phobia10.6CD40LG, CD79A
42ocular hypotension10.6CD40LG, CD79A
43subpulmonary stenosis10.6AQP1, AQP4
44differentiating neuroblastoma10.6CD40LG, CD79A
45anatomical narrow angle borderline glaucoma10.6CD79A, IL1B
46tenosynovitis10.5CD40LG, CD79A
47catatrichy10.5F5, MTHFR
48microscopic colitis10.5F2, F5
49pregnancy loss, recurrent 110.5F5, MTHFR
50somatoform disorder10.5CD40LG, CD79A, EPO

Graphical network of the top 20 diseases related to Intracranial Hypertension:



Diseases related to intracranial hypertension

Symptoms for Intracranial Hypertension

About this section

UMLS symptoms related to Intracranial Hypertension:


restlessness, weakness, actual discomfort, active range of joint movement reduced, swallowing problem, bulging fontanelle, activity intolerance, other symptoms involving nervous and musculoskeletal systems, withdrawal symptoms, breast engorgement, agitation, nausea

Drugs & Therapeutics for Intracranial Hypertension

About this section

Drugs for Intracranial Hypertension (from DrugBank, HMDB, Dgidb, PharmGKB, IUPHAR, NovoSeek, BitterDB):

(show top 50)    (show all 213)
idNameStatusPhaseClinical TrialsCas NumberPubChem Id
1
Morphineapproved, investigationalPhase 485557-27-25288826
Synonyms:
(-)(5.alpha.,6.alpha.)-7,8-Didehydro-4,5-epoxy-17-methylmorphinan-3,6-diol
(-)-Heroin hydrochloride
(-)-Morphine
(-)Morphine sulfate
(5R,6S,9R,13S,14R)-4,5-Epoxy-N-methyl-7-morphinen-3,6-diol
(5alpha,6alpha)-17-Methyl-7,8-didehydro-4,5-epoxymorphinan-3,6-diol
(5alpha,6alpha)-17-methyl-7,8-didehydro-4,5-epoxymorphinan-3,6-diol
(5alpha,6alpha)-7,8-Didehydro-4,5-epoxy-17-methylmorphinan-3,6-diol
(5alpha,6alpha)-Didehydro-4,5-epoxy-17-methylmorphinan-3,6-diol
(7R,7AS,12BS)-3-METHYL-2,3,4,4A,7,7A-HEXAHYDRO-1H-4,12-METHANO[1]BENZOFURO[3,2-E]ISOQUINOLINE-7,9-DIOL
(7R,7AS,12bs)-3-methyl-2,3,4,4a,7,7a-hexahydro-1H-4,12-methano[1]benzofuro[3,2-e]isoquinoline-7,9-diol
(−)-morphine
17-methyl-7,8-didehydro-4,5alpha-epoxymorphinan-3,6alpha-diol
4,5alpha-Epoxy-17-methyl-7-morphinen-3,6alpha-diol
4-methyl-(13R,14S)-12-oxa-4-azapentacyclo[9.6.1.01,13.05,17.07,18]octadeca-7(18),8,10,15-tetraene-10,14-diol
47106-99-0
57-27-2
6211-15-0 (sulfate (2:1) (salt) pentahydrate)
64-31-3
64-31-3 (sulfate (2:1) (salt) anhydrous)
7,8-Didehydro-4,5-epoxy-17-methyl-morphinan-3,6-diol
7,8-Didehydro-4,5-epoxy-17-methylmorphinan-3,6-diol
8053-16-5
85201-37-2
Apokyn
Astramorph PF
Avinza
BIDD:GT0147
C01516
CCRIS 5762
CHEBI:17303
CHEMBL70
CID5288826
Cube juice
D-(-)-Morphine
DB00295
DEA No. 9300
DepoDur
Depodur
Diacetylmorphine hydrochloride
Diamorphine hydrochloride
Dolcontin
Dreamer
Dulcontin
Duramorph
Duramorph PF
Duromorph
EINECS 200-320-2
Epimorph
HSDB 2134
Hard stuff
Heroin hydrochloride
Heroine hydrochloride
Hocus
Infumorph
 
Kadian
LS-91748
M-Eslon
M.O.S
MOI
MORPHINE SULFATE
MORPHINE, (5A,6A)-7,8-DIDEHYDRO-4,5-EPOXY-17-METHYLMORPHINIAN-3,6-DIOL, MORPHIUM, MORPHIA, DOLCONTIN, DUROMORPH, MORPHINA, NEPENTHE
MS Contin
MS/L
MS/S
MSIR
Meconium
MolPort-003-849-273
Morfina
Morfina [Italian]
Morphia
Morphin
Morphin [German]
Morphina
Morphina [Italian]
Morphine
Morphine Extra-Forte
Morphine Forte
Morphine H.P
Morphine Sulfate
Morphine [BAN]
Morphinism
Morphinum
Morphitec
Morphium
Morpho
Moscontin
Ms Contin
Ms Emma
NSC11441
Nepenthe
O,O'-Diacetylmorphine hydrochloride
OMS Concentrate
Oramorph SR
Ospalivina
RMS
RMS Uniserts
Rescudose
Roxanol
Roxanol 100
Roxanol UD
SDZ 202-250
SDZ202-250
Statex
Statex Drops
Statex SR
UNII-76I7G6D29C
Unkie
l-Morphine
morphine
nchembio.317-comp1
nchembio.64-comp1
2
DexmedetomidineapprovedPhase 4, Phase 3, Phase 2470113775-47-668602, 5311068, 56032
Synonyms:
(+)-4-((S)-alpha,2,3-Trimethylbenzyl)imidazole
(+)-4-((S)-alpha,2,3-trimethylbenzyl)imidazole
(+)-medetomidine
(S)-medetomidine
113775-47-6
4-[(1S)-1-(2,3-Dimethylphenyl)ethyl]-1H-imidazole
4-[(1S)-1-(2,3-dimethylphenyl)ethyl]-1H-imidazole
5-[(1S)-1-(2,3-dimethylphenyl)ethyl]-1H-imidazole
AC1NSJXT
C07450
CHEBI:4466
CHEMBL778
CID5311068
D00514
DEXMEDETOMIDINE
Dexdor (T)
 
Dexmedetomidin
Dexmedetomidina
Dexmedetomidine
Dexmedetomidine (USAN/INN)
Dexmedetomidine Hydrochloride
Dexmedetomidinum
Dexmédétomidine
MPV 1440
MPV-1440
Medetomidina [Spanish]
Medetomidine
Medetomidinum [Latin]
NCGC00025347-01
PRECEDEX
Precedex
Precedex (TN)
Tocris-2023
ZINC04632106
3
LabetalolapprovedPhase 4, Phase 3, Phase 23036894-69-63869
Synonyms:
2-Hydroxy-5-(1-hydroxy-2-((1-methyl-3-phenylpropyl)amino)ethyl)benzamide
2-hydroxy-5-[1-hydroxy-2-(4-phenylbutan-2-ylamino)ethyl]benzamide
2-hydroxy-5-{1-hydroxy-2-[(1-methyl-3-phenylpropyl)amino]ethyl}benzamide
3-Carboxamido-4-hydroxy-alpha-((1-methyl-3-phenylpropylamino)methyl)benzyl alcohol
36894-69-6
5-(1-Hydroxy-2-(1-methyl-3-phenylpropylamino)ethyl)salicylamide
AB00053659
AC-18747
AC1L1GW8
AH 5158
AH-5158
Albetol
BPBio1_000170
BRD-A07440155-003-05-6
BSPBio_000154
BSPBio_003142
C07063
CHEBI:6343
CHEMBL429
CID3869
D08106
DB00598
DivK1c_000474
EINECS 253-258-3
HSDB 6537
IDI1_000474
Ibidomide
KBio1_000474
KBio2_002087
KBio2_004655
KBio2_007223
KBio3_002642
 
KBioGR_000727
KBioSS_002087
L001344
LS-26936
Labetalol
Labetalol (INN)
Labetalol Hydrochloride
Labetalol [INN:BAN]
Labetalolum
Labetalolum [INN-Latin]
Labetolol
Lopac0_000687
MolPort-003-898-140
NCGC00015595-06
NCGC00089800-02
NINDS_000474
NORMOZIDE
Prestwick0_000277
Prestwick1_000277
Prestwick2_000277
Prestwick3_000277
SBB067266
SPBio_000905
SPBio_002373
Sch-19927
Spectrum2_000863
Spectrum3_001581
Spectrum4_000184
Spectrum5_001010
Spectrum_001607
TL8002725
Trandate
UNII-R5H8897N95
labetalol
4
HydralazineapprovedPhase 4, Phase 24286-54-43637
Synonyms:
(1Z)-1(2H)-Phthalazinone hydrazone
(2H)-Phthalazinone hydrazone
1(2H)-Phthalazinone hydrazone
1(2H)-Phthalazinone, hydrazone
1-Hydrazinophthalazine
1-Phthalazinylhydrazine
304-20-1 (mono-hydrochloride)
5-25-17-00412 (Beilstein Handbook Reference)
6-Hydralazine
86-54-4
AC1L1GDN
AC1Q4UY1
AKOS000122609
Apresolin
Apresoline
Apressin
Apressin (pharmaceutical)
Apressoline
Aprezolin
BA 5968
BRD-K82103381-003-03-7
BRN 0132615
BSPBio_002130
C 5968
C-5068
C-5968
C07040
C8H8N4
CAS-304-20-1
CCRIS 5385
CHEBI:5775
CHEMBL276832
CID3637
Ciba 5968
D08044
DB01275
DivK1c_000117
EC-000.1838
EINECS 201-680-3
HLZ
Hidral
Hidral (TN)
Hidralazin
Hidralazina
Hidralazina [INN-Spanish]
Hidralazina [Spanish]
Hipoftalin
Hydralazin
Hydralazine
Hydralazine (INN)
Hydralazine Hydrochloride
Hydralazine [INN:BAN]
 
Hydralazine hydrochloride
Hydralazinum
Hydralazinum [INN-Latin]
Hydrallazin
Hydrallazine
Hydrazinophthalazine
Hydrazone 1(2H)-phthalazinone
Hypophthalin
IDI1_000117
Idralazina
Idralazina [DCIT]
Idralazina [Italian]
InChI=1/C8H8N4/c9-11-8-7-4-2-1-3-6(7)5-10-12-8/h1-5H,9H2,(H,11,12)
KBio1_000117
KBio2_001355
KBio2_003923
KBio2_006491
KBio3_001350
KBioGR_000349
KBioSS_001355
LS-109171
Lopac-H-1753
Lopac0_000593
MolPort-000-876-738
MolPort-001-794-088
NCGC00015501-01
NCGC00015501-02
NCGC00015501-05
NCGC00162199-01
NCIOpen2_001484
NINDS_000117
NSC 126699
NSC126699
Oprea1_207681
Oprea1_416878
Phthalazin-1-ylhydrazine
Praparat 5968
Prestwick0_000169
Prestwick1_000169
Prestwick2_000169
SPBio_000977
SPBio_001958
ST50512087
Spectrum2_000969
Spectrum3_000455
Spectrum4_000005
Spectrum5_000822
Spectrum_000875
UNII-26NAK24LS8
WLN: T66 CNNJ BMZ
ZINC12360535
[2H-Phthalazin-(1Z)-Ylidene]-Hydrazine Hydrochloride
hydralazine
phthalazin-1-ylhydrazine
5
RemifentanilapprovedPhase 4409132875-61-760815
Synonyms:
1-Piperidinepropanoic acid, 4-(methoxy-carbonyl)-4-((1-oxopropyl)phenylamino)-, methyl ester
132539-07-2 (mono-hydrochloride)
132875-61-7
3-(4-methoxycarbonyl-4-((1-oxopropyl)phenylamino)-1-piperidine)propanoic acid methyl ester
4-carboxy-4-(n-phenylpropionamido)-1-piperidinepropionic acid dimethyl ester
AC1L1TZ8
AC1Q5ZGR
BIDD:GT0029
C08021
CHEBI:8802
CHEMBL1005
CID60815
D08473
DB00899
 
DEA No. 9739
GI 87084B
GI 87084X
GI87084B
L001266
LS-115982
MolPort-004-286-006
REMIFENTANIL
Remifentanil (INN)
Remifentanil [INN:BAN]
Remifentanyl
UNII-P10582JYYK
Ultiva
Ultiva (TN)
methyl 1-(3-methoxy-3-oxopropyl)-4-(N-propanoylanilino)piperidine-4-carboxylate
6
ClevidipineapprovedPhase 4, Phase 3, Phase 220166432-28-6
Synonyms:
 
Clevidipine butyrate
Cleviprex
7
EsmololapprovedPhase 4, Phase 3, Phase 148103598-03-459768
Synonyms:
(+-)-Esmolol
(+-)-Methyl P-(2-hydroxy-3-(isopropylamino)propoxy)hydrocinnamate
(+-)-methyl p-(2-hydroxy-3-(isopropylamino)propoxy)hydrocinnamate
103598-03-4
3-[4-(2-Hydroxy-3-isopropylamino-propoxy)-phenyl]-propionic acid methyl ester
81147-92-4
81161-17-3 (Hydrochloride)
84057-94-3
AC-12058
AC1L1RWQ
AC1Q5ZXA
ASL 8052-001
BRN 5287174
Benzenepropanoic acid, 4-(2-hydroxy-3-((1-methylethyl)amino)propoxy)-, methyl ester
Brevibloc
C06980
CHEBI:4856
CHEMBL768
CID59768
 
D07916
DB00187
ESMOLOL
Esmolol
Esmolol (INN)
Esmolol Hydrochloride
Esmolol [INN:BAN]
HMS2090P06
L001332
LS-185019
LS-31121
Methyl 4-(2-hydroxy-3-((1-methylethyl)amino)propoxy)benzenepropanoate
Methyl P-(2-hydroxy-3-(isopropylamino)propoxy)hydrocinnamate
MolPort-005-933-593
UNII-MDY902UXSR
methyl 3-[4-({2-hydroxy-3-[(1-methylethyl)amino]propyl}oxy)phenyl]propanoate
methyl 3-[4-[2-hydroxy-3-(propan-2-ylamino)propoxy]phenyl]propanoate
methyl 3-{4-[2-hydroxy-3-(propan-2-ylamino)propoxy]phenyl}propanoate
methyl p-(2-hydroxy-3-(isopropylamino)propoxy)hydrocinnamate
methyl p-[2-hydroxy-3-(isopropylamino)propoxy]hydrocinnamate
8
CosyntropinapprovedPhase 42416960-16-016129617
Synonyms:
16960-16-0
ATCH (1-24)
Adrenocorticotropic hormone 1-24
COSYNTROPIN
Corticotropin-(1-24)
Corticotropin-(1-24) tetracosapeptide
Cortrosyn
Cortrosyn (TN)
 
Cosyntropin
Cosyntropin (USAN)
D00284
SYSMEHFRWGKPVGKKRRPVKVYP
SerTyrSerMetGluHisPheArgTrpGlyLysProValGlyLysLysArgArgProValLysValTyrPro
Tetracosactide
Tetracosactide (INN)
alpha(1-24)-Corticotrophin
beta(1-24)-Corticotrophin
9
Mannitolapproved, investigationalPhase 4, Phase 3, Phase 2, Phase 124269-65-8453, 6251
Synonyms:
(2R,3R,4R,5R)-Hexane-1,2,3,4,5,6-hexaol
(2R,3R,4R,5R)-Hexane-1,2,3,4,5,6-hexol
(2R,3R,4R,5R)-hexane-1,2,3,4,5,6-hexol
(L)-Mannitol
1,2,3,4,5,6-Hexanehexol
123897-58-5
133-43-7
15719_ALDRICH
15719_RIEDEL
33440_RIEDEL
33440_SIGMA
36413-61-3
4-01-00-02841 (Beilstein Handbook Reference)
5149-40-6
63559_FLUKA
63559_SIGMA
63560_FLUKA
63565_FLUKA
63565_SIGMA
69-65-8
75398-80-0
85085-15-0
87-78-5
AB1002081
AC-12776
AC1L1M49
AC1Q28E5
AI3-19511
AR-1J3861
Ambap69-65-8
BRN 1721898
C00392
C6H14O6
CCRIS 369
CHEBI:16899
CHEMBL689
CID6251
Cordycepate
Cordycepic acid
D-(-)-Mannitol
D-Mannitol
D-Mannitol (JP15)
D-mannite
D-mannitol
D00062
D008353
DL-Mannitol
Diosmol
ED1D1E61-FEFB-430A-AFDC-D1F4A957FC3D
EINECS 200-711-8
EINECS 201-770-2
Fraxinine
HSDB 714
Hexahydroxyhexane
Hexanhexol
Invenex
Isotol
LS-1588
LS-89250
M0044
M1902_SIGMA
M4125_SIAL
M8429_SIAL
M9546_SIAL
M9647_SIAL
MANNITOL 10% W/ DEXTROSE 5% IN DISTILLED WATER
MANNITOL 15% W/ DEXTROSE 5% IN SODIUM CHLORIDE 0.45%
 
MANNITOL 25%
MANNITOL 5% W/ DEXTROSE 5% IN SODIUM CHLORIDE 0.12%
MLS001335977
MLS001335978
MTL
Manicol
Manitol
Maniton S
Maniton-S
Manna Sugar
Manna sugar
Mannazucker
Mannidex
Mannidex 16700
Mannigen
Mannistol
Mannit
Mannit p
Mannite
Mannitol
Mannitol (USP)
Mannitol (VAN)
Mannitol 10%
Mannitol 10% In Plastic Container
Mannitol 15%
Mannitol 15% In Plastic Container
Mannitol 20%
Mannitol 20% In Plastic Container
Mannitol 5%
Mannitol 5% In Plastic Container
Mannitol [USAN]
Mannitolum
Mannogem 2080
Marine Crystal
Marine crystal
MolPort-003-927-039
Mushroom sugar
NCGC00164246-01
NCI-C50362
NSC 407017
NSC 9256
OSMITROL 10% IN WATER IN PLASTIC CONTAINER
OSMITROL 15% IN WATER IN PLASTIC CONTAINER
OSMITROL 20% IN WATER IN PLASTIC CONTAINER
OSMITROL 5% IN WATER IN PLASTIC CONTAINER
Osmitrol
Osmitrol (TN)
Osmitrol 10% In Water
Osmitrol 15% In Water
Osmitrol 20% In Water
Osmitrol 5% In Water
Osmofundin
Osmosal
Resectisol
Resectisol In Plastic Container
SDM No. 35
SMR000857324
SORBITOL-MANNITOL IN PLASTIC CONTAINER
Sorbitol-Mannitol
TL806434
UNII-3OWL53L36A
ZINC02041302
bmse000099
cpd without stereochemical designation
e 421
e-421
e421
manita
mannitol
10
NicardipineapprovedPhase 4, Phase 3, Phase 12955985-32-54474
Synonyms:
2-(Benzylmethylamino)ethyl methyl 1,4-dihydro-2,6-dimethyl-4-(m-nitrophenyl)pyridine-3,5-dicarboxylate
3,5-Pyridinedicarboxylic acid, 1,4-dihydro-2,6-dimethyl-4-(3-nitrophenyl)-, 2-(benzylmethylamino)ethyl methyl ester
3,5-Pyridinedicarboxylic acid, 1,4-dihydro-2,6-dimethyl-4-(3-nitrophenyl)-, methyl 2-(methyl(phenylmethyl)amino)ethyl ester
3,5-Pyridinedicarboxylic acid, 1,4-dihydro-2,6-dimethyl-4-(3-nitrophenyl)-, methyl 2-[methyl(phenylmethyl)amino]ethyl ester
3,5-Pyridinedicarboxylic acid, 1,4-dihydro-2,6-dimethyl-4-(3-nitrophenyl)-,2-(benzylmethylamino)ethyl methyl ester
5-O-[2-[benzyl(methyl)amino]ethyl] 3-O-methyl 2,6-dimethyl-4-(3-nitrophenyl)-1,4-dihydropyridine-3,5-dicarboxylate
55985-32-5
AB00514658
AC-19947
AC1L1I8Y
AKOS001637090
Ambap55985-32-5
BIDD:GT0621
BPBio1_000623
BRD-A26711594-001-02-7
BRD-A26711594-003-05-6
BRN 0504321
BSPBio_000565
BSPBio_001389
BSPBio_002943
Bio1_000088
Bio1_000577
Bio1_001066
Bio2_000109
Bio2_000589
C07264
C26H29N3O6
CBiol_001802
CHEBI:507549
CHEMBL1484
CID4474
Cardene
Cardene (TN)
Cardene IV
Cardene Iv
Cardene SR
D08270
DB00622
DivK1c_000540
EINECS 259-932-3
HMS1791F11
HMS1989F11
HMS2089C09
IDI1_000540
IDI1_033859
KBio1_000540
 
KBio2_000109
KBio2_001852
KBio2_002677
KBio2_004420
KBio2_005245
KBio2_006988
KBio3_000217
KBio3_000218
KBio3_002443
KBioGR_000109
KBioGR_000744
KBioSS_000109
KBioSS_001852
L000715
LS-131263
Lopac0_000809
MolPort-002-484-049
NCGC00015747-06
NCGC00162262-01
NCGC00162262-02
NCGC00162262-03
NCGC00162262-04
NINDS_000540
Nicardipine (INN)
Nicardipine Hydrochloride
Nicardipine LA
Nicardipine [INN:BAN]
Nicardipino
Nicardipino [INN-Spanish]
Nicardipinum
Nicardipinum [INN-Latin]
Oprea1_436998
Prestwick0_000383
Prestwick1_000383
Prestwick2_000383
Prestwick3_000383
SPBio_001490
SPBio_002486
Spectrum2_001415
Spectrum3_001452
Spectrum4_000422
Spectrum5_001320
Spectrum_001372
UNII-CZ5312222S
Y-93
methyl 2-[methyl(phenylmethyl)amino]ethyl 2,6-dimethyl-4-(3-nitrophenyl)-1,4-dihydropyridine-3,5-dicarboxylate
nicardipine
11
AspirinapprovedPhase 4, Phase 2, Phase 3102950-78-22244
Synonyms:
11126-35-5
11126-37-7
1oxr
2-(ACETYLOXY)benzoic acid
2-(Acetyloxy)benzoate
2-(Acetyloxy)benzoic acid
2-Acetoxybenzenecarboxylic acid
2-Acetoxybenzoate
2-Acetoxybenzoic acid
2-Carboxyphenyl acetate
2349-94-2
26914-13-6
50-78-2
7 Select Adult Chewable Aspirin
7 Select Aspirin
8-hour Bayer
98201-60-6
A 5376
A.S.A
A.S.A.
A.S.A. Empirin
A.S.A. empirin
A2093_SIGMA
A3160_SIGMA
A5376_SIGMA
A6810_SIGMA
AB1003266
AC 5230
AC1L1D8U
AC1Q1LA0
ACETYLSALICYLIC ACID
AI3-02956
AIN
AKOS000118884
ASA
Acenterine
Acesal
Acetal
Acetard
Aceticyl
Acetilsalicilico
Acetilum acidulatum
Acetisal
Acetol
Acetonyl
Acetophen
Acetosal
Acetosalic acid
Acetosalin
Acetoxybenzoic acid
Acetylin
Acetylsal
Acetylsalicylate
Acetylsalicylic acid
Acetylsalicylsaeure
Acetylsalicylsaure
Acetylsalycilic acid
Acetyonyl
Acetysal
Acetysalicylic acid
Acide 2-(acetyloxy)benzoique
Acide acetylsalicylique
Acide acétylsalicylique
Acido O-acetil-benzoico
Acido acetilsalicilico
Acidum acetylsalicylicum
Acimetten
Acisal
Acylpyrin
Adiro
Adult Chewable Low Dose Aspirin
Adult Low Dose Aspirin
Adult Low Dose Aspirin Enteric Safety Coated
Adult Low Dose Enteric Coated Aspirin
Adult Low Strength Aspirin
Aloxiprimum
Asacard
Asagran
Asaphen
Asatard
Ascoden-30
Ascriptin Maximum Strength Buffered Aspirin
Ascriptin Regular Strength Buffered Aspirin
Aspalon
Aspec
Aspergum
Aspi-cor
Aspir Low
Aspir-Mox
Aspirdrops
Aspirin
Aspirin (JP15/USP)
Aspirin 81 Mg
Aspirin 81 Mg Low Dose
Aspirin Adult Low Dose
Aspirin Adult Low Strength
Aspirin Adult Low Strength Aspirin
Aspirin Adult low strength
Aspirin Chewable Low Dose
Aspirin Delayed Release
Aspirin EC
Aspirin EXTRA STRENGTH
Aspirin Ec
Aspirin Enteric
Aspirin Enteric Coated
Aspirin Enteric Coated Low Dose
Aspirin Enteric Safety Coated
Aspirin Enteric Safety-Coated
Aspirin Low Dose
Aspirin Low Dose Chewable
Aspirin Low Dose Enteric Coated
Aspirin Low Dose Safety Coated
Aspirin Low Strength
Aspirin Nsaid
Aspirin Regular Strength
Aspirin Regular Strength regular strength
Aspirin Regular strength
Aspirin Safety Coated
Aspirin Safety Coated Adult Low Dose
Aspirin Safety coated
Aspirin Thin coated
Aspirin [BAN:JAN]
Aspirin adult low dose
Aspirin adult low strength
Aspirin enteric safety coated
Aspirin low dose
Aspirin low dose chewable
Aspirin low dose enteric coated
Aspirin regular strength
Aspirina 03
Aspirine
Aspiring
Asprin
Aspro
Aspro Clear
Asteric
Azetylsalizylsaeure
Azetylsalizylsäure
BIDD:GT0118
BRN 0779271
Bay-e-4465
Bayer
Bayer Advanced Aspirin Extra Strength
Bayer Advanced Aspirin Regular Strength
Bayer Aspirin 8 Hour
Bayer Aspirin Regimen Chewable Low Dose Aspirin Orange
Bayer Aspirin Regimen Regular Strength
Bayer Buffered
Bayer Chewable - Aspirin Regimen Low Dose Aspirin Cherry Flavored
Bayer Extra Strength Aspirin For Migraine Pain
Bayer Fast Release
Bayer Genuine Aspirin
Bayer Low Dose
Bayer Plus
Bayer Plus Extra Strength
Bayer Womens
Benaspir
Bi-prin
Bialpirina
Bialpirinia
Buffered Aspirin
Bufferin
Bufferin LOW DOSE BUFFERED ASPIRIN
C01405
CCRIS 3243
CHEBI:15365
CHEMBL25
CID2244
Caprin
Cardioaspirin
Cardioaspirina
Care One Aspirin
Cemirit
Chewable Adult Low Dose Aspirin
Chewable Aspirin
Chewable Low Dose Aspirin
Claradin
Clariprin
Colfarit
Contrheuma retard
Coricidin
Critical Care Aspirin To Go
Crystar
D00109
D001241
DB00945
Decaten
Delgesic
Dg Health Aspirin
Direct Safety Aspirin
Dispril
DivK1c_000555
Dolean pH 8
Duramax
ECM
EINECS 200-064-1
EU-0100038
Easprin
Easprin (TN)
Ec-81aspirin Enteric Coated
Ecolen
Ecotrin
Ecotrin Regular Strength
Empirin
Empirin with Codeine
Endosprin
Endydol
Enteric Aspirin
Enteric Coated Aspirin
Enteric Coated Aspirin Regular Strength
Enteric Coated Aspirin Regular strength
Enteric Coated Aspirin regular strength
Enteric Coated Asprin 81 Mg
Enteric Coated Low Dose Aspirin
 
Enteric Safety Coated Aspirin
Entericin
Enterophen
Enterosarein
Enterosarine
Entrophen
Equaline Aspirin
Equaline Aspirin adult low dose
Equate Aspirin
Equate Aspirin chewable
Extren
Fasprin
Flanax Aspirin Pain Reliever
Formucare Aspirin
Genuine Aspirin
Globentyl
Globoid
Good Neighbor Pharmacy Aspirin
Good Neighbor Pharmacy Aspirin Enteric Safety Coated
Good Neighbor Pharmacy Aspirin orange flavor chewable
Good Sense Aspirin
Good Sense Aspirin Enteric Safety Coated
HMS1920E13
HMS2090G03
HMS2091K13
HMS501L17
HSDB 652
Handy Solutions Genuine Aspirin Bayer
Health Mart Aspirin
Health Mart Regular Strength Enteric Coated Aspirin
Health Sense Adult Chewable Low Strength Aspirin
Health Sense Aspirin 81
Health Sense Ecpirin
Healthy Accents Aspirin
Helicon
Henry Schein Aspirin
I14-7505
IDI1_000555
Idragin
Istopirin
KBio1_000555
KBio2_001725
KBio2_002271
KBio2_004293
KBio2_004839
KBio2_006861
KBio2_007407
KBio3_002149
KBio3_002751
KBioGR_000398
KBioGR_002271
KBioSS_001725
KBioSS_002272
Kapsazal
Kroger Value Aspirin
Kyselina 2-acetoxybenzoova
Kyselina acetylsalicylova
LS-143
Leader Aspirin
Leader Cardinal Health Aspirin
Leader Low Dose Aspirin
Levius
Lopac-A-5376
Lopac0_000038
Low Dose Adult Aspirin
Low Dose Aspirin
Low Dose Aspirin 81 Mg Safety Coated
Low Dose Aspirin Enteric Safety Coated
Low Dose Asprin
Low Dose Chewable Aspirin
Low Dose Miniprin Enteric Safety Coated
Low Dose Pain Relief Aspirin
Low Strength Chewable Aspirin
Low-dose Aspirin
MLS001055329
MLS001066332
MLS001336045
MLS001336046
Magnecyl
Measurin
Medi First Plus Aspirin
Medi-first Aspirin
Medique Aspirin
Medisyl
Micristin
Micro-coated Aspirin
Miniprin
MolPort-000-871-622
NCGC00015067-01
NCGC00015067-04
NCGC00015067-09
NCGC00090977-01
NCGC00090977-02
NCGC00090977-03
NCGC00090977-04
NCGC00090977-05
NCGC00090977-06
NCGC00090977-07
NCI60_002222
NINDS_000555
NSC 27223
NSC27223
NSC406186
Neuronika
North Aspirin
Novasen
Novid
Nu-seals
Nu-seals aspirin
O-(Acetyloxy)benzoate
O-(Acetyloxy)benzoic acid
O-Acetoxybenzoate
O-Acetoxybenzoic acid
O-Acetylsalicylic acid
O-Carboxyphenyl acetate
O-accetylsalicylic acid
O-acetylsalicylic acid
PL-2200
Pain Relief Aspirin
Pain Relief Aspirin Low Dose
Persistin
Pharbest Aspirin 325mg
Pharbest Regular Strength Aspirin
Pharmacin
Pirseal
Plus Pharma NSAID 325 mg
Plus Pharma Nsaid Aspirin
Polopirin
Polopiryna
Premaspin
R16CO5Y76E [UNII]
Rapid Comfort Aspirin
Regular Strength Aspirin
Regular Strength Aspirin Ec
Regular Strength Buffered Aspirin
Regular Strength Enteric Aspirin
Regular Strength Enteric Coated Aspirin
Regular Strength Pain Relief
Regular Strength Tri-buffered Aspirin
Rexall Aspirin
Rheumin tabletten
Rheumintabletten
Rhodine
Rhonal
Ronal
Rugby Aspirin
Rx Act Aspirin
S-211
SMR000059138
SP 189
SPBio_001838
SPECTRUM1500130
ST075414
Safety Coated Aspirin
Safety Coated Enteric Aspirin
Salacetin
Salcetogen
Saletin
Salicylic acid acetate
Salicylic acid, acetate
Salospir
Smart Health Aspirin regular strength
Smart Sense Aspirin
Solfrin
Solprin
Solprin acid
Solpyron
Solupsan
Solves - Aspirin Cherry
Spectrum2_001899
Spectrum3_001295
Spectrum4_000099
Spectrum5_000740
Spectrum_001245
Spira-Dine
St. Joseph
St. Joseph Aspirin for Adults
St. Joseph Chewable Aspirin
St. Joseph Safety Coated Aspirin
Sunmark Aspirin
Sunmark Aspirin Regular Strength
Sunmark Aspirin adult low strength
Sunmark Aspirin low dose
Supac
Tasprin
Temperal
Toldex
Topcare Aspirin
Tri-buffered Aspirin
Triaminicin
Triple-sal
UNII R16CO5Y76E
UNII-R16CO5Y76E
UNII=R16CO5Y76E
UNM-0000306102
Uncoated Aspirin
Value Pharma Aspirin Pain Reliever
Value Pharmapain Reliever Extra Strength
Vanquish
WLN: QVR BOV1
XAXA
Xaxa
Yasta
ZORprin
Zee Aspirin
aspirin
cMAP_000006
component of Midol
component of Synirin
nchem.859-comp6
o-Acetoxybenzoic acid
o-Carboxyphenyl acetate
o-acetoxybenzoic acid
o-carboxyphenyl acetate
ácido acetilsalicílico
12
Minocyclineapproved, investigationalPhase 417310118-90-85281021
Synonyms:
(2Z,4S,4aS,5aR,12aS)-2-[amino(hydroxy)methylidene]-4,7-bis(dimethylamino)-10,11,12a-trihydroxy-4a,5,5a,6-tetrahydro-4H-tetracene-1,3,12-trione
(4S,4AS,5AR,12AS)-4,7-BIS(DIMETHYLAMINO)-3,10,12,12A-TETRAHYDROXY-1,11-DIOXO-1,4,4A,5,5A,6,11,12A-OCTAHYDROTETRACENE-2-CARBOXAMIDE
(4S,4AS,5ar,12as)-4,7-bis(dimethylamino)-3,10,12,12a-tetrahydroxy-1,11-dioxo-1,4,4a,5,5a,6,11,12a-octahydrotetracene-2-carboxamide
10118-90-8
13614-98-7 (mono-hydrochloride)
4,7-Bis(dimethylamino)-1,4,4a,5,5a,6,11,12a-octahydro-3,10,12,12a-tetrahydroxy-1,11-dioxo-2-naphthacenecarboxamide
4708-96-7
7-Dimethylamino-6-demethyl-6-deoxytetracycline
AC1NQXWM
Arestin
BRN 3077644
Bio-0062
Borymycin
C07225
C23H27N3O7
CHEBI:50694
CHEBI:529981
CHEMBL1434
CHEMBL259172
CID5281021
CL 59806
CRL-1605 & Minocycline
D05045
Dynacin
HMS2090D03
HSDB 3130
LMPK07000002
 
LS-93850
Lactoferrin B & Minocycline
Lactoferrin H & Minocycline
MINO
MIY
Minociclina
Minociclina [INN-Spanish]
Minociclinum
Minocin
Minocin (Hydrochloride)
Minocline
Minocyclin
Minocycline
Minocycline (USAN/INN)
Minocycline Hydrochloride
Minocycline Monohydrochloride
Minocycline [USAN:BAN:INN]
Minocyclinum
Minocyclinum [INN-Latin]
NCGC00178854-01
NSC 141993
NSC141993
Solodyn
UNII-FYY3R43WGO
Vectrin (Hydrochloride)
Ximino
minociclinum
minocycline
nchembio.559-comp1
13
AtracuriumapprovedPhase 46564228-79-147319
Synonyms:
1-[(3,4-Dimethoxyphenyl)methyl]-2-[3-({5-[(3-{1-[(3,4-dimethoxyphenyl)methyl]-6,7-dimethoxy-2-methyl-1,2,3,4-tetrahydroisoquinolin-2-ium-2-yl}propanoyl)oxy]pentyl}oxy)-3-oxopropyl]-6,7-dimethoxy-2-methyl-1,2,3,4-tetrahydroisoquinolin-2-ium
2,2'-{pentane-1,5-diylbis[oxy(3-oxopropane-3,1-diyl)]}bis[1-(3,4-dimethoxybenzyl)-6,7-dimethoxy-2-methyl-1,2,3,4-tetrahydroisoquinolinium]
5-[3-[1-[(3,4-dimethoxyphenyl)methyl]-6,7-dimethoxy-2-methyl-3,4-dihydro-1H-isoquinolin-2-ium-2-yl]propanoyloxy]pentyl 3-[1-[(3,4-dimethoxyphenyl)methyl]-6,7-dimethoxy-2-methyl-3,4-dihydro-1H-isoquinolin-2-ium-2-yl]propanoate
64228-79-1
64228-81-5 (besylate)
AB00514743
AC1L2HUF
AC1Q67HR
ATRACURIUM
Atracurium
Atracurium Dibesylate
BPBio1_000011
BRN 1523633
 
BSPBio_000009
C07548
C53H70N2O12
CHEBI:2914
CHEMBL1360
CID47319
DB00732
HMS2090I21
LS-86151
MolPort-005-932-641
Prestwick1_000005
Prestwick2_000005
Prestwick3_000005
SPBio_001930
UNII-2GQ1IRY63P
14
LymecyclineapprovedPhase 44992-21-25280963, 24757945
Synonyms:
(+)-N-(5-Amino-5-carboxypentylaminomethyl)-4-dimethylamino-1,4,4a,5,5a,6,11,12a-octahydro-3,6,10,12,12a-pentahydroxy-6-methyl-1,11-dioxonaphthacene-2-carboxamide
7-Chlorotetracycline
992-21-2
Acronize PD
Aureociclin
Aureomicina
Aurofac
Aurofac 10
Biovetin
CHEBI:59040
CLTC
Centraureo
Chlorotetracycline
Chlortetracyclin
 
Chlortetracycline
Chlortetracyclinium chloride
Chrusomykine
D06884
DB00256
Limeciclina
Lymecycline (INN)
Lymecyclinum
N(2)-(((+)-5-Amino-5-carboxypentylamino)methyl)tetracycline
N(6)-[({[(4S,4aS,5aS,6S,12aS)-4-(dimethylamino)-3,6,10,12,12a-pentahydroxy-6-methyl-1,11-dioxo-1,4,4a,5,5a,6,11,12a-octahydrotetracen-2-yl]carbonyl}amino)methyl]-L-lysine
N-Lysinomethyltetracycline
N6-((4-(Dimethylamino)-1,4,4a,5,5a,6,11,12a-octahydro-3,6,10,12,12a-pentahydroxy-6-methyl-1,11-dioxo-2-naphthacenecarboxamido)methyl)lysine
Orospray
Tetracycline-L-methylene lysine
Tetracycline-L-methylenelysine
Tetrlysal 300
15
IsotretinoinapprovedPhase 41154759-48-25538, 5282379
Synonyms:
(13-cis)-Retinoate
(13-cis)-Retinoic acid
(13cis)-retinoic acid
(2Z,4E,6E,8E)-3,7-dimethyl-9-(2,6,6-trimethylcyclohexen-1-yl)nona-2,4,6,8-tetraenoic acid
(2Z,4E6E,8E)-3,7-dimethyl-9-(2,6,6-trimethylcyclohex-1-en-1-yl)nona-2,4,6,8-tetraenoic acid
(7E,9E,11E,13Z)-retinoic acid
(7e,9e,11e,13Z)-Retinoic acid
13 Cis-Retinoic Acid
13 cis retinoic acid
13-RA
13-cis RA
13-cis retinoic acid
13-cis-Retinoate
13-cis-Retinoic acid
13-cis-Vitamin A acid
13-cis-Vitamin a acid
3,7-Dimethyl-9-(2,6,6-trimethyl-1-cyclohexen-1-yl)2-cis-4-trans-6-trans-8-trans-nonatetraenoic acid
4-09-00-02388 (Beilstein Handbook Reference)
4759-48-2
97950-17-9
AC-15388
AC1NQZZ4
Absorica
Accutane
Accutane (TN)
Ambap302-79-4
Amnesteem
BML2-E07
BPBio1_000080
BRD-K76723084-001-05-9
BRN 1885770
BSPBio_000072
BSPBio_001331
BSPBio_003345
CCRIS 4286
CHEBI:6067
CHEMBL547
CID5282379
CIP-Isotretinoin
CPD000471891
Claravis
Clarus
D00348
D015474
EINECS 225-296-0
EU-0101081
Epuris
HMS1361C13
HMS1568D14
HMS1791C13
HMS1921D08
HMS1989C13
HMS2092N07
HSDB 3929
IDI1_033801
Isotane
Isotretinoin
Isotretinoin (USP)
 
Isotretinoin Retinoic acid
Isotretinoin Zinc Salt, 13 cis Isomer
Isotretinoin Zinc Salt, 13-cis-Isomer
Isotretinoin [USAN:BAN:INN]
Isotretinoin [USAN:INN:BAN]
Isotretinoina
Isotretinoine
Isotretinoine [INN-French]
Isotretinoino
Isotretinoino [INN-Spanish]
Isotretinoinum
Isotretinoinum [INN-Latin]
Isotrex
LMPR01090021
LS-143465
Lopac0_001081
MLS001074662
MolPort-003-666-394
Myorisan
NCGC00094358-01
NCGC00094358-02
NCGC00094358-03
NCGC00094358-04
NCGC00094358-05
NCGC00094358-06
NCGC00094358-07
NCGC00094358-08
NCGC00094358-09
NCGC00094358-13
Neovitamin A acid
Neovitamin a acid
Prestwick2_000256
Prestwick3_000256
Prestwick_642
R 3255
R3255_SIGMA
Retinoate
Retinoic acid
Ro 4 3780
Ro 4-3780
Ro 43780
Ro-4-3780
Ro-43780
Roaccutan
Roaccutane
Roacutan
SAM002548955
SMR000471891
SPECTRUM1502013
Sotret
Sotret (TN)
Spectrum5_001795
Spectrum5_001937
Teriosal
UNII-EH28UP18IF
Zenatane
cis-RA
cis-Retinoate
cis-Retinoic acid
isotretinoino
16
Doxycyclineapproved, investigationalPhase 4219564-25-054671203, 5281011
Synonyms:
(2E,4S,4aR,5S,5aR,6R,12aS)-2-[amino(hydroxy)methylidene]-4-(dimethylamino)-5,10,11,12a-tetrahydroxy-6-methyl-4a,5,5a,6-tetrahydro-4H-tetracene-1,3,12-trione
(2Z)-2-[amino(hydroxy)methylidene]-4-(dimethylamino)-5,10,11,12a-tetrahydroxy-6-methyl-4a,5,5a,6-tetrahydro-4H-tetracene-1,3,12-trione
(2Z,4S,4aR,5S,5aR,6R)-2-[amino(hydroxy)methylidene]-4-(dimethylamino)-5,10,11,12a-tetrahydroxy-6-methyl-4a,5,5a,6-tetrahydro-4H-tetracene-1,3,12-trione
(2Z,4S,4aR,5S,5aR,6R,12aS)-2-[amino(hydroxy)methylidene]-4-(dimethylamino)-5,10,11,12a-tetrahydroxy-6-methyl-4a,5,5a,6-tetrahydro-4H-tetracene-1,3,12-trione
(4S,4AR,5S,5ar,6R,12as)-4-(dimethylamino)-3,5,10,12,12a-pentahydroxy-6-methyl-1,11-dioxo-1,4,4a,5,5a,6,11,12a-octahydrotetracene-2-carboxamide
(4S,4aR,5S,5aR,6R,12aS)-4-(dimethylamino)-3,5,10,12,12a-pentahydroxy-6-methyl-1,11-dioxo-1,4,4a,5,5a,6,11,12a-octahydrotetracene-2-carboxamide
10597-92-9
17086-28-1 (mono-hydrate)
2-Naphthacenecarboxamide, 4-(dimethylamino)-1,4,4a,5,5a,6,11,12a-octahydro-3,5,10,12,12a-pentahydroxy-6-methyl-1,11-dioxo-, (4S,4aR,5S,5aR,6R,12aS)
24390-14-5
41411-66-9 (6-epimer, mono-hydrochloride)
5-Hydroxy-alpha-6-deoxytetracycline
564-25-0
6-Deoxyoxytetracycline
6-Deoxytetracycline
6-alpha-Deoxy-5-oxytetracycline
6-alpha-deoxy-5-oxytetracycline
69935-17-7 (mono-hydrochloride, di-hydrate)
6alpha-Deoxy-5-oxytetracycline
6α-deoxy-5-oxytetracycline
7164-70-7
7264-10-0
94088-85-4 (calcium salt (1:2))
AB08 (*Fosfatex)
AC1NQXW7
AC1NS4CW
AC1NUYS8
AC1O8PYM
Adoxa
Alodox
Alti-Doxycycline
Apo-Doxy
Atridox
Azudoxat
BCBcMAP01_000024
BIDD:GT0146
BMY-28689
BPBio1_000951
BSPBio_000863
BSPBio_001936
BU-3839T
C06973
CHEBI:50845
CHEMBL1433
CID5281011
CID5353597
CID5463943
CID6713981
CPD001550033
D07876
DB00254
DMSC (*Fosfatex)
DOXCYCLINE ANHYDROUS
DOXY
DOXYCYCLINE CALCIUM
DOXYCYCLINE MONOHYDRATE
Deoxymykoin
DivK1c_000345
Doryx
Dossiciclina
Dossiciclina [DCIT]
Doxcycline anhydrous
Doxiciclina
Doxiciclina [INN-Spanish]
Doxiciclina [Italian]
Doxitard
Doxivetin
Doxy 100
Doxy-Caps
Doxy-Puren
Doxy-Tabs
Doxycen
Doxychel
Doxychel (TN)
Doxycin
Doxycyclin
Doxycycline
Doxycycline (200mg/day) or Placebo
Doxycycline (INN)
 
Doxycycline (TN)
Doxycycline (anhydrous)
Doxycycline (internal use)
Doxycycline Hyclate
Doxycycline Monohydrate
Doxycycline anhydrous
Doxycycline hyclate
Doxycycline hydrochloride
Doxycycline-Chinoin
Doxycyclinum
Doxycyclinum [INN-Latin]
Doxysol
Doxytec
Doxytetracycline
EINECS 209-271-1
GS-3065 (*monohydrate)
HMS2090E06
HSDB 3071
Hydramycin
IDI1_000345
Investin
Jenacyclin
KBio1_000345
KBio2_001287
KBio2_003855
KBio2_006423
KBio3_001156
KBioGR_001133
KBioSS_001287
LS-187766
LS-93868
Liviatin
Lopac0_000405
MolPort-002-507-423
Monodox
Monodox (*monohydrate)
Morgidox
NCGC00161602-01
NCGC00161602-03
NCGC00161602-04
NCGC00167961-01
NCGC00179395-01
NINDS_000345
NSC633557
Novo-Doxylin
Nu-Doxycycline
Ocudox
Oracea
Prestwick0_000852
Prestwick1_000852
Prestwick2_000852
Prestwick3_000852
Ronaxan
SAM002589932
SMP1_000107
SPBio_000246
SPBio_002784
STOCK1N-34341
Spanor
Spectrum2_000143
Spectrum3_000408
Spectrum4_000527
Spectrum5_000947
Spectrum_000807
Supracyclin
UNII-334895S862
UPCMLD-DP021
UPCMLD-DP021:001
Vibra-tabs
Vibramycin
Vibramycin (*monohydrate)
Vibramycin Monohydrate
Vibramycin Novum
Vibramycine
Vibravenos
Vivox (*Hyclate)
alpha-6-Deoxy-5-hydroxytetracycline
alpha-6-Deoxyoxytetracycline
alpha-Doxycycline
doxycycline
17
Clopidogrelapproved, nutraceuticalPhase 4, Phase 3, Phase 2717120202-66-6, 113665-84-260606
Synonyms:
( )-(S)-Clopidogrel
(+)-(S)-Clopidogrel
(+)-Clopidogrel
(S)-Clopidogrel
(S)-Methyl 2-(2-chlorophenyl)-2-(6,7-dihydrothieno[3,2-c]pyridin-5(4H)-yl)acetate
113665-84-2
AC-19024
AC1L1TKZ
AC1Q41I9
BIDD:GT0284
BRD-K27721098-065-02-9
BSPBio_003211
C16H16ClNO2S
CGE
CHEBI:37941
CHEMBL1771
CID60606
CLOPIDOGREL SULFATE
CPD000550475
Clopidogrel
Clopidogrel (INN)
Clopidogrel (TN)
Clopidogrel Bisulfate
Clopidogrel [BAN:INN]
Clopidogrel [Ban:Inn]
Clopidogrel [INN:BAN]
Clopidogrel bisulfate
Clopidogrel bisulphate
Clopidogrel sulfate
Clopidogrelum
D07729
DB00758
DivK1c_000787
HMS2090O21
HMS502H09
HSDB 7430
 
IDI1_000787
Isocover
KBio1_000787
KBio2_000545
KBio2_003113
KBio2_005681
KBio3_002431
KBioGR_000689
KBioSS_000545
LS-172232
MLS001165708
MLS001195633
MLS001304711
Methyl (+)-(S)-alpha-(o-chlorophenyl)-6,7-dihydrothieno(3,2-c)pyridine-5(4H)-acetate
MolPort-002-885-817
MolPort-003-845-991
NCGC00163329-02
NINDS_000787
Plavix
Plavix (TN)
SAM002589956
SMR000550475
SPBio_000463
SR 25990
STK580572
STOCK5S-27782
Spectrum2_000512
Spectrum3_001606
Spectrum4_000175
Spectrum_000105
TL8000400
UNII-A74586SNO7
Zyllt
clopidogrel
clopidogrel, (+)(S)-isomer
methyl (2S)-(2-chlorophenyl)(6,7-dihydrothieno[3,2-c]pyridin-5(4H)-yl)ethanoate
methyl (2S)-2-(2-chlorophenyl)-2-(6,7-dihydro-4H-thieno[3,2-c]pyridin-5-yl)acetate
nchem.651-comp8
18parecoxibexperimentalPhase 439119828
19
butyric acidexperimentalPhase 4, Phase 2292107-92-6264
Synonyms:
1-Butanoate
1-Butanoic acid
1-Butyrate
1-Butyric acid
1-Propanecarboxylate
1-Propanecarboxylic acid
Butanate
Butanic acid
Butanoate
Butanoic acid
Buttersaeure
Butyrate
 
Butyric acid
Ethylacetate
Ethylacetic acid
Honey robber
Kyselina maselna
N-Butanoate
N-Butanoic acid
N-Butyrate
N-Butyric acid
Propanecarboxylate
Propanecarboxylic acid
Propylformate
Propylformic acid
20Adrenergic AgonistsPhase 4, Phase 3, Phase 2, Phase 12331
21Adrenergic alpha-2 Receptor AgonistsPhase 4, Phase 3, Phase 2790
22Adrenergic alpha-AgonistsPhase 4, Phase 3, Phase 2, Phase 11300
23Adrenergic AgentsPhase 4, Phase 3, Phase 2, Phase 14204
24Adrenergic AntagonistsPhase 4, Phase 3, Phase 2, Phase 11253
25Central Nervous System DepressantsPhase 4, Phase 3, Phase 2, Phase 110016
26Cyclooxygenase InhibitorsPhase 4, Phase 2, Phase 32225
27Hormones, Hormone Substitutes, and Hormone AntagonistsPhase 4, Phase 3, Phase 29988
28Hormone AntagonistsPhase 4, Phase 3, Phase 210002
29HormonesPhase 4, Phase 3, Phase 211748
30Pharmaceutical SolutionsPhase 4, Phase 2, Phase 3, Phase 17004
31Natriuretic AgentsPhase 4, Phase 2, Phase 3, Phase 11403
32(1-6)-alpha-glucomannanPhase 414
33AnestheticsPhase 4, Phase 2, Phase 3, Phase 17385
34Vasodilator AgentsPhase 4, Phase 3, Phase 2, Phase 12926
35diureticsPhase 4, Phase 2, Phase 3, Phase 11194
36Antirheumatic AgentsPhase 4, Phase 2, Phase 38496
37Cyclooxygenase 2 InhibitorsPhase 4538
38Peripheral Nervous System AgentsPhase 4, Phase 2, Phase 3, Phase 118510
39Anesthetics, GeneralPhase 4, Phase 3, Phase 22274
40Anti-Inflammatory Agents, Non-SteroidalPhase 4, Phase 2, Phase 33549
41Neurotransmitter AgentsPhase 4, Phase 3, Phase 2, Phase 114795
42NarcoticsPhase 4, Phase 22709
43Anesthetics, IntravenousPhase 4, Phase 3, Phase 21943
44Hypnotics and SedativesPhase 4, Phase 3, Phase 22032
45Analgesics, OpioidPhase 4, Phase 22304
46Antihypertensive AgentsPhase 4, Phase 3, Phase 2, Phase 13618
47Adrenergic beta-1 Receptor AntagonistsPhase 4, Phase 3, Phase 1292
48Analgesics, Non-NarcoticPhase 4, Phase 2, Phase 35184
49Anti-Inflammatory AgentsPhase 4, Phase 2, Phase 38478
50calcium channel blockersPhase 4, Phase 3, Phase 2, Phase 11743

Interventional clinical trials:

(show top 50)    (show all 183)
idNameStatusNCT IDPhase
1Mannitol Versus Hypertonic Saline Solution in the Treatment of Elevated Intracranial PressureCompletedNCT00447018Phase 4
2Correlation of Measured and Calculated Serum Osmolality During Hyperosmolar Drugs Infusion in Patients After CraniotomyCompletedNCT02037815Phase 4
3A Post Marketing Surveillance Study for NutropinAq® in Adults With Growth Hormone DeficiencyCompletedNCT00455884Phase 4
4Mannitol Improves Cerebral Oxygen SaturationCompletedNCT02091180Phase 4
5Cosyntropin Versus Epidural Blood Patch (EBP) for Treatment of Treatment of Post Dural Puncture HeadacheCompletedNCT02394457Phase 4
6A Comparison of the Perioperative Hemodynamic Effects of Remifentanil and Esmolol in Intracranial SurgeryCompletedNCT01628562Phase 4
7A Pilot Study to Evaluate Efficacy and Safety of Clevidipine in Neurosurgical PatientsCompletedNCT00952081Phase 4
8Effect of Parecoxib on Post-craniotomy PainCompletedNCT00455117Phase 4
9Comparison of Dexmedetomidin and Remifentanil for the Effect on Airway Reflex and Hemodynamic Response During Emergence in Patients Undergoing CraniotomyCompletedNCT01365923Phase 4
10Treatment of Intracranial Hypertension of Severe Tramatic Brain Injured Patients. Physiopathologic Effects of Neuromuscular Blocking AgentsRecruitingNCT02404779Phase 4
11Antiacne Medications Pseudotumor CerebriRecruitingNCT02149615Phase 4
12Comparison of 20% Mannitol and 3% Hypertonic Saline for Cerebral Relaxation During Elective Supratentorial CraniotomiesRecruitingNCT01745081Phase 4
13The Efficacy and Safety of Cleviprex in Ventriculostomy Patients Requiring IV Antihypertensive TherapyRecruitingNCT01042574Phase 4
14Registry Study of Stenting for Symptomatic Intracranial Artery Stenosis in ChinaRecruitingNCT01968122Phase 4
15IV Double and Triple Concentrated Nicardipine for Stroke and ICHRecruitingNCT00325793Phase 4
16Comparison of 2 Doses of Mannitol on Post Traumatic Intracranial Hypertension and Cerebral MonitoringTerminatedNCT00795587Phase 4
17Cerebral Hemodynamic Effects of Hypertonic Solutions in Severely Head-Injured PatientsTerminatedNCT00125229Phase 4
18Effect of Intrathoracic Pressure Regulation on Traumatic Brain InjuryTerminatedNCT01824589Phase 4
19ShuntCheck Accuracy in Detecting Shunt Obstruction Normal Pressure Hydrocephalus (NPH) PatientsWithdrawnNCT00793416Phase 4
20Comparison of Allogenix Plus Demineralized Bone Matrix and Autogenous Bone Dust Versus Autogenous Bone Dust Alone in Ossification of Small Calvarial Defects, a Pilot Study.WithdrawnNCT01006148Phase 4
21The Effect of Clevidipine on Intracranial Pressure and Cerebral Perfusion Pressure (CCP) in Brain Injured PatientsWithdrawnNCT01526876Phase 4
22The Evaluation of Clevidipine in Patients Requiring ICP Monitoring and IV Antihypertensive TherapyWithdrawnNCT01910532Phase 4
23Idiopathic Intracranial Hypertension Treatment TrialCompletedNCT01003639Phase 2, Phase 3
24Preventive Sodium Lactate and Traumatic Brain InjuryCompletedNCT00995683Phase 2, Phase 3
25Impact of Ventricular Catheter Used With Antimicrobial Agents on Patients With a Ventricular CatheterCompletedNCT00286104Phase 3
26Anti-Oxidant Supplementation for the Prevention of Acute Mountain SicknessCompletedNCT00664001Phase 3
27Clevidipine in the Treatment of Patients With Acute Hypertension and Intracerebral Hemorrhage (ACCELERATE)CompletedNCT00666328Phase 3
28Stenting vs. Aggressive Medical Management for Preventing Recurrent Stroke in Intracranial StenosisCompletedNCT00576693Phase 3
29Antihypertensive Treatment of Acute Cerebral Hemorrhage-IICompletedNCT01176565Phase 3
30Clinical Value of Noninvasive Intracranial Pressure MeasurementRecruitingNCT02130219Phase 2, Phase 3
31Esmolol Versus Dexmedetomidine During Intracranial ProceduresRecruitingNCT02563288Phase 3
32Randomized Trial of Erythropoietin During Cerebral MalariaRecruitingNCT00697164Phase 2, Phase 3
33Normal Pressure Hydrocephalus Treatment by AcetazolamideRecruitingNCT02163330Phase 3
34Efficacy Study of Hypothermia Plus Magnesium Sulphate(MgSO4) in the Management of Term and Near Term Babies With Hypoxic Ischemic EncephalopathyRecruitingNCT01646619Phase 3
35The DECRA Trial: Early Decompressive Craniectomy in Patients With Severe Traumatic Brain InjuryActive, not recruitingNCT00155987Phase 3
36Mannitol as Adjunct Therapy for Childhood Cerebral MalariaActive, not recruitingNCT00113854Phase 3
37Treatment Protocol for Hemophagocytic Lymphohistiocytosis 2004Active, not recruitingNCT00426101Phase 3
38Comparison of Effectiveness of Pentobarbital and Thiopental in Patients With Refractory Intracranial HypertensionTerminatedNCT00622570Phase 3
39Mannitol vs HS to Treat ICHT After Severe TBI : Comparison on PtiO2 and Microdialysis ValuesTerminatedNCT01028339Phase 3
40Sodium-Lactate and Traumatic Brain InjuryTerminatedNCT00319345Phase 2, Phase 3
41Hypertonic Saline vs. Mannitol for Elevated Intercranial PressureTerminatedNCT01111682Phase 3
42Hypothermia in Children After TraumaTerminatedNCT00222742Phase 3
43Clinical Trial of Growth Hormone in MPS I, II, and VITerminatedNCT00748969Phase 2, Phase 3
44Induced Hypertension for Treatment of Delayed Cerebral Ischaemia After Aneurysmal Subarachnoid HaemorrhageTerminatedNCT01613235Phase 3
45Induced Hypertension for Delayed Cerebral Ischaemia After Aneurysmal Subarachnoid Haemorrhage:a Feasibility StudyTerminatedNCT00841633Phase 3
46HyperHAES Versus Placebo - Effect on Intracranial Pressure in SAH PatientsCompletedNCT00199706Phase 2
47Brain Tissue Oxygen Monitoring in Traumatic Brain Injury (TBI)CompletedNCT00974259Phase 2
48Dexamethasone in Cryptococcal MeningitisCompletedNCT00000776Phase 2
49Astragalus Membranaceus for Brain Edema Induced by Hemorrhagic StrokeCompletedNCT01428401Phase 2
50Effects of Saline on Circulation in ChildrenCompletedNCT01668277Phase 2

Search NIH Clinical Center for Intracranial Hypertension

Inferred drug relations via UMLS65/NDF-RT43:


Cochrane evidence based reviews: intracranial hypertension

Genetic Tests for Intracranial Hypertension

About this section

Anatomical Context for Intracranial Hypertension

About this section

MalaCards organs/tissues related to Intracranial Hypertension:

33
Brain, Liver, Bone, Kidney, Breast, Heart, T cells

Animal Models for Intracranial Hypertension or affiliated genes

About this section

MGI Mouse Phenotypes related to Intracranial Hypertension:

38
idDescriptionMGI Source AccessionScoreTop Affiliating Genes
1MP:00107717.5CD40LG, EPO, F2, F5, HSD11B1, IL1B
2MP:00107686.3AQP1, AQP4, CD40LG, EPO, F2, F5
3MP:00053876.1AQP4, CD40LG, CD79A, F2, GFAP, HSD11B1
4MP:00053975.9AQP1, AQP4, CD40LG, CD79A, EPO, F2
5MP:00036315.8AQP1, AQP4, CD40LG, CD79A, F2, F5
6MP:00053855.7AQP1, AQP4, CD40LG, EPO, F2, F5
7MP:00053765.0AQP1, AQP4, CD40LG, CD79A, EPO, F2

Publications for Intracranial Hypertension

About this section

Articles related to Intracranial Hypertension:

(show top 50)    (show all 733)
idTitleAuthorsYear
1
Evidence for potential involvement of pro-inflammatory adipokines in the pathogenesis of idiopathic intracranial hypertension. (27193133)
2016
2
Bariatric surgery as a treatment for idiopathic intracranial hypertension: a systematic review. (26499350)
2015
3
Optical Coherence Tomography Can Detect Intracranial Hypertension in Young Children with Craniosynostosis. (26397534)
2015
4
Hypothermia for Intracranial Hypertension after Traumatic Brain Injury. (26444221)
2015
5
Intradiploic epidermoid cyst with intracranial hypertension syndrome: Report of two cases and literature review. (26433925)
2015
6
Asymmetric Papilledema in Idiopathic Intracranial Hypertension: Comment. (26196848)
2015
7
Obesity and the role of nonsurgical and surgical weight reduction in idiopathic intracranial hypertension. (24296369)
2014
8
Evidence of Multidomain Mild Cognitive Impairment in Idiopathic Intracranial Hypertension. (25383589)
2014
9
Baseline OCT Measurements in the Idiopathic Intracranial Hypertension Treatment Trial: Part II. Correlations and Relationship to Clinical Features. (25370513)
2014
10
Effects of lowering cerebrospinal fluid pressure on the shape of the peripapillary retina in intracranial hypertension. (25406288)
2014
11
Intracranial Hypertension in Siblings with Infantile Hypercalcemia. (25305753)
2014
12
Intracranial hypertension in a patient preparing for gestational surrogacy with leuprolide acetate and estrogen. (23612241)
2013
13
Increased levels of interleukins 2 and 17 in the cerebrospinal fluid of patients with idiopathic intracranial hypertension. (24179731)
2013
14
Venous hypertension as the cause of intracranial hypertension in patients with transverse sinus dural arteriovenous fistula. (22495458)
2013
15
Conjunctival oedema as a potential objective sign of intracranial hypertension: a short illustrated review and three case reports. (23793919)
2013
16
Effect of mannitol on cerebrovascular pressure reactivity in patients with intracranial hypertension. (24090636)
2013
17
Can ocular ultrasound predict intracranial hypertension? A pilot diagnostic accuracy evaluation in a UK emergency department. (22327166)
2013
18
MRI findings of elevated intracranial pressure in cerebral venous thrombosis versus idiopathic intracranial hypertension with transverse sinus stenosis. (24019557)
2013
19
Lumboperitoneal shunt for idiopathic intracranial hypertension: patients' selection and outcome. (21956361)
2012
20
Intracranial pressure/cerebral perfusion pressure-targeted management of life-threatening intracranial hypertension complicating diabetic ketoacidosis-associated cerebral edema: a case report. (22766587)
2012
21
Update on the pathophysiology and management of idiopathic intracranial hypertension. (22423118)
2012
22
Intracranial hypertension secondary to psychogenic polydipsia. (22787354)
2012
23
Letters to the editor: Stenting and idiopathic intracranial hypertension. (23020766)
2012
24
Acute surgical management in idiopathic intracranial hypertension. (23239783)
2012
25
Blood flow velocities during experimental intracranial hypertension in pigs. (22889577)
2012
26
Response to intracranial hypertension treatment as a predictor of death in patients with severe traumatic brain injury. (21214327)
2011
27
Intracranial hypertension in two cases of craniometaphyseal dysplasia: differing surgical options. (21806345)
2011
28
MR imaging findings in patients with secondary intracranial hypertension. (21511864)
2011
29
Idiopathic intracranial hypertension. (21788420)
2011
30
Transverse sinus stenting for idiopathic intracranial hypertension: a review of 52 patients and of model predictions. (21799038)
2011
31
Idiopathic intracranial hypertension and facial palsy: case report and review of the literature. (20921567)
2010
32
Successful management of refractory intracranial hypertension from acute hyperammonemic encephalopathy in a woman with ornithine transcarbamylase deficiency. (20422467)
2010
33
Cushing's disease and idiopathic intracranial hypertension: case report and review of underlying pathophysiological mechanisms. (20739379)
2010
34
Hypertonic saline more efficacious than mannitol in lethal intracranial hypertension model. (19309542)
2010
35
Absence of aquaporin-4 antibodies in patients with idiopathic intracranial hypertension. (20232212)
2010
36
Intracranial hypertension: A rare presentation of lupus nephritis. (21559160)
2010
37
Decompressive craniectomy: surgical control of traumatic intracranial hypertension may improve outcome. (21574279)
2010
38
Prolonged hypothermia as a bridge to recovery for cerebral edema and intracranial hypertension associated with fulminant hepatic failure. (19728177)
2009
39
Relevance of intracranial hypertension for cerebral metabolism in aneurysmal subarachnoid hemorrhage. Clinical article. (19284237)
2009
40
Elevated cerebrospinal fluid (CSF) leptin in idiopathic intracranial hypertension (IIH): evidence for hypothalamic leptin resistance? (18771566)
2009
41
Effectiveness of ketamine in decreasing intracranial pressure in children with intracranial hypertension. (19569909)
2009
42
Idiopathic intracranial hypertension in men and the relationship to sleep apnea. (18923134)
2009
43
Follow-up of mild papilledema in idiopathic intracranial hypertension with optical coherence tomography. (19011007)
2009
44
Spinal cord astrocytoma presenting as "idiopathic" intracranial hypertension. (16298472)
2006
45
Rebound intracranial hypertension after treatment of spontaneous intracranial hypotension. (16834710)
2006
46
Obstructive hydrocephalus and intracranial hypertension caused by a giant macroprolactinoma. Prompt response to medical treatment. (16205966)
2006
47
Images in clinical medicine. Papilledema associated with intracranial hypertension. (11346809)
2001
48
Gliomatosis cerebri or benign intracranial hypertension? (7644408)
1995
49
Idiopathic intracranial hypertension (pseudotumor cerebri): MR imaging. (2909098)
1989
50
Benign intracranial hypertension without papilledema: case report. (503301)
1979

Variations for Intracranial Hypertension

About this section

Expression for genes affiliated with Intracranial Hypertension

About this section
Search GEO for disease gene expression data for Intracranial Hypertension.

Pathways for genes affiliated with Intracranial Hypertension

About this section

GO Terms for genes affiliated with Intracranial Hypertension

About this section

Biological processes related to Intracranial Hypertension according to GeneCards Suite gene sharing:

(show all 14)
idNameGO IDScoreTop Affiliating Genes
1positive regulation of calcidiol 1-monooxygenase activityGO:006055910.3IL1B, TNF
2positive regulation of membrane protein ectodomain proteolysisGO:005104410.3IL1B, TNF
3sequestering of triglycerideGO:003073010.3IL1B, TNF
4regulation of establishment of endothelial barrierGO:190314010.3IL1B, TNF
5response to folic acidGO:005159310.3MTHFR, OGG1
6positive regulation of chemokine biosynthetic processGO:004508010.2IL1B, TNF
7positive regulation of fever generationGO:003162210.2IL1B, TNF
8negative regulation of lipid catabolic processGO:005099510.1IL1B, TNF
9glycerol transportGO:001579310.1AQP1, AQP4
10regulation of I-kappaB kinase/NF-kappaB signalingGO:004312210.1IL1B, TNF
11positive regulation of phagocytosisGO:00507669.9IL1B, TNF
12regulation of immunoglobulin secretionGO:00510239.7CD40LG, TNF
13leukocyte migrationGO:00509009.5F2, IL1B, TNF
14positive regulation of NF-kappaB transcription factor activityGO:00510928.7CD40LG, IL1B, TNF

Sources for Intracranial Hypertension

About this section
2CDC
14ExPASy
15FDA
16FMA
24GTR
25HGMD
26HMDB
27ICD10
28ICD10 via Orphanet
29ICD9CM
30IUPHAR
31KEGG
34MedGen
36MeSH
37MESH via Orphanet
38MGI
41NCI
42NCIt
43NDF-RT
46NINDS
47Novoseek
49OMIM
50OMIM via Orphanet
54PubMed
55QIAGEN
60SNOMED-CT via Orphanet
64Tumor Gene Family of Databases
65UMLS
66UMLS via Orphanet